Sign in to continue:

Monday, February 9th, 2026

JD Health International Inc: Technical Buy with Promising Upside Targets

Date of Report: September 25, 2024
Broker: CGS International Securities


Stock Overview

Company Name: JD Health International Inc
Stock Code: 6618
Last Price: 26.75

Investment Recommendation

JD Health International Inc is identified as a Technical Buy in the report with the following entry price levels and targets:

Entry Prices:

  • 26.75
  • 23.84
  • 21.60

Stop Loss:

  • 19.35

Target Prices

The report outlines multiple target prices for JD Health International Inc:

  • Target 1: 31.60
  • Target 2: 36.30
  • Target 3: 40.00
  • Target 4: 45.40

These targets indicate a strong potential for growth and are appealing for investors looking for significant returns.


Technical Indicators and Analysis

JD Health International Inc is recommended for technical buying based on the following factors:

  • The stock’s last price is listed at 26.75, with several upward target price levels indicating potential gains.
  • A stop loss is recommended at 19.35, providing a safeguard for investors.

The report highlights that the stock is showing positive technical signals, making it an attractive option for those focused on technical market analysis.

Singapore Stock Market 2025 Outlook: Year-End Rally, SMC Opportunities & Top Value Picks | DBS Insights 1

Broker Name: DBS Date of Report: 07 Oct 2025 Excerpt from DBS report. Report Summary DBS maintains a positive outlook for the Singapore market ahead of a potential year-end rally, driven by MAS market...

Singapore Banks: The Star Performers You Shouldn’t Ignore in 2024

Singapore Banks: The Star Performers You Shouldn’t Ignore in 2024 Why Banks Are Winning Big Singapore’s big three banks—DBS, OCBC, and UOB—have been riding high amid the Straits Times Index’s strong performance in 2024....

SingTel Stock Outlook 2025: Dividend Yield, Valuation, and Growth Forecasts Explained

CGS International June 17, 2025 SingTel’s Dividend Appeal: Attractive Yields, Limited Upside, and Asset Monetization in Focus for 2025 Overview: SingTel’s Strategic Position in 2025 SingTel enters FY26 with an enhanced focus on shareholder...